401 related articles for article (PubMed ID: 32104546)
1. Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?
Loktionov A
World J Gastrointest Oncol; 2020 Feb; 12(2):124-148. PubMed ID: 32104546
[TBL] [Abstract][Full Text] [Related]
2. Non-Invasive Colorectal Cancer Screening: An Overview.
Tepus M; Yau TO
Gastrointest Tumors; 2020 Jul; 7(3):62-73. PubMed ID: 32903904
[TBL] [Abstract][Full Text] [Related]
3. Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model
Stürzlinger H; Conrads-Frank A; Eisenmann A; Invansits S; Jahn B; Janzic A; Jelenc M; Kostnapfel T; Mencej Bedrac S; Mühlberger N; Siebert U; Sroczynski G;
Ger Med Sci; 2023; 21():Doc06. PubMed ID: 37426885
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing.
Roth JA; deVos T; Ramsey SD
Am Health Drug Benefits; 2019 Sep; 12(5):256-262. PubMed ID: 32015794
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
7. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
8. Faecal Diagnostic Biomarkers for Colorectal Cancer.
Cruz A; Carvalho CM; Cunha A; Crespo A; Iglesias Á; García-Nimo L; Freitas PP; Cubiella J
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771730
[TBL] [Abstract][Full Text] [Related]
9. Epi proColon
Shirley M
Mol Diagn Ther; 2020 Aug; 24(4):497-503. PubMed ID: 32557236
[TBL] [Abstract][Full Text] [Related]
10. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications.
Loktionov A; Soubieres A; Bandaletova T; Francis N; Allison J; Sturt J; Mathur J; Poullis A
Br J Cancer; 2020 Jul; 123(2):252-260. PubMed ID: 32398859
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive fecal testing for colorectal cancer.
Zou J; Xiao Z; Wu Y; Yang J; Cui N
Clin Chim Acta; 2022 Jan; 524():123-131. PubMed ID: 34756863
[TBL] [Abstract][Full Text] [Related]
12. Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis.
Mo S; Wang H; Han L; Xiang W; Dai W; Zhao P; Pei F; Su Z; Ma C; Li Q; Wang Z; Cai S; Wang H; Liu R; Cai G
Front Oncol; 2021; 11():643136. PubMed ID: 33718241
[TBL] [Abstract][Full Text] [Related]
13. Epi proColon
Lamb YN; Dhillon S
Mol Diagn Ther; 2017 Apr; 21(2):225-232. PubMed ID: 28155091
[TBL] [Abstract][Full Text] [Related]
14. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study.
Johnson DA; Barclay RL; Mergener K; Weiss G; König T; Beck J; Potter NT
PLoS One; 2014; 9(6):e98238. PubMed ID: 24901436
[TBL] [Abstract][Full Text] [Related]
15. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
17. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]